Wellcome Y9C 100 Pill - white capsule/oblong, 16mm
Generic Name: zidovudine
Pill with imprint Wellcome Y9C 100 is White, Capsule/Oblong and has been identified as Retrovir 100 mg. It is supplied by ViiV Healthcare Company.
Retrovir is used in the treatment of Reduction of Perinatal Transmission of HIV; HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Retrovir 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Wellcome Y9C 100
Retrovir
- Generic Name
- zidovudine
- Imprint
- Wellcome Y9C 100
- Strength
- 100 mg
- Color
- White
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- ViiV Healthcare Company
- Inactive Ingredients
-
corn starch,
magnesium stearate,
microcrystalline cellulose,
sodium starch glycolate type A potato,
ferrosoferric oxide,
dimethicone,
shellac,
soya lecithin,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
49702-0211 | ViiV Healthcare |
54868-1974 (Discontinued) | Physicians Total Care Inc. (repackager) |
52959-0509 | H.J. Harkins Company, Inc. (repackager) |
49999-0386 | Lake Erie Medical and Surgical Supply (repackager) |
Related images for "Wellcome Y9C 100"
More about Retrovir (zidovudine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
- En español
Patient resources
- Retrovir oral/injection drug information
- Retrovir (Zidovudine Intravenous) (Advanced Reading)
- Retrovir (Zidovudine Oral) (Advanced Reading)
- Retrovir (Zidovudine Syrup)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.